Research programme: neurodegenerative gene therapies - MeiraGTx/Weill Cornell Medicine
Latest Information Update: 28 Dec 2016
At a glance
- Originator MeiraGTx; Weill Cornell Medical College
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Neurodegenerative disorders
Most Recent Events
- 12 Dec 2016 Early research in Neurodegenerative disorders in USA